Sandu Pharmaceuticals Limited (BOM:524703)

Market Cap	505.17M
Revenue (ttm)	671.92M
Net Income (ttm)	15.52M
Shares Out	9.66M
EPS (ttm)	1.60
PE Ratio	32.68
Forward PE	n/a
Dividend	0.80 (1.55%)
Ex-Dividend Date	Sep 19, 2024

Volume	4,729
Average Volume	3,373
Open	51.16
Previous Close	51.54
Day's Range	51.00 - 52.98
52-Week Range	43.75 - 69.50
Beta	0.13
RSI	45.19
Earnings Date	Jun 5, 2025

About Sandu Pharmaceuticals

Sandu Pharmaceuticals Limited manufactures and sells ayurvedic medicines under the SANDU brand in India and internationally. The company offers sandu mahasudarshan kadha no 1, sandu abhayarishta, sandu pathyadi kadha, sandu makarprash, sandu gulkand pravalyukta, sandu acivin herbal antacid, sandu ashwagandharishta, sandu amritarishta, sandu hemocleen excellent blood purifier, and sandu vanari granules. It also provides mahasudarshan kadha, amritarishta, tab. samshamani vati, pathajeevani, vasa cough syrup, whoopin syrup, somajeevani, drakshasav...

• Industry: Pharmaceutical Preparations
• Founded: 1899
• Employees: 283
• Stock Exchange: Bombay Stock Exchange
• Ticker Symbol: 524703

Financial Performance

In 2024, Sandu Pharmaceuticals's revenue was 671.92 million, a decrease of -0.13% compared to the previous year's 672.81 million. Earnings were 15.52 million, an increase of 6.19%.